Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of TECAR on Chronic Discogenic Sciatica

NCT: NCT07841405 · RECRUITING

NCT IDNCT07841405
StatusRECRUITING
Start Date2026-09-21
Completion2027-01-21
SponsorCairo University (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to evaluate the effect of TECAR therapy on pain, functional disability and electrophysiological parameters in adults with chronic discogenic sciatica . The main questions it aims to answer are: • Is there significant effect of TECAR therapy on pain, functional disability and Electrophysiological parameters (H-reflex latency and amplitude) ? Researchers will compare effect of adding TECAR therapy to conventional physical therapy program (TENS, hot pack, stretching exercises and core stability exercises) Vs conventional physical therapy program alone to see if there is a beneficial effect of adding TECAR therapy to physical therapy program Participants in study group will receive TECAR therapy in addition to conventional PT program while participants in control group will receive conventional PT program

Frequently Asked Questions

What is Effect of TECAR on Chronic Discogenic Sciatica?

Effect of TECAR on Chronic Discogenic Sciatica is a clinical trial registered under NCT07841405. Current status: RECRUITING.

What is the status of NCT07841405?

The current status of NCT07841405 (Effect of TECAR on Chronic Discogenic Sciatica) is: RECRUITING.

When did Effect of TECAR on Chronic Discogenic Sciatica start?

Effect of TECAR on Chronic Discogenic Sciatica started on 2026-09-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑